Medical Prognosis Institute A/S Stock Nasdaq Copenhagen
Equities
MPIT
DK0060732477
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 246K 1.7M 336K |
---|---|---|---|---|---|
Net income 2024 * | -16M -110M -21.84M | Net income 2025 * | -28M -193M -38.22M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.51
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Medical Prognosis Institute A/S
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 46 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
1st Jan change | Capi. | |
---|---|---|
+4.05% | 111B | |
+11.45% | 105B | |
-12.74% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.10% | 16.96B | |
+2.53% | 13.7B | |
+36.64% | 12.45B |